Cellcyte Genetics Corp (CCYG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| TOTAL | $25 | $2 | $9 | $16 | $23 |
| Non-Current Assets | |||||
| PPE Net | 13 | N/A | N/A | 1 | 3 |
| Intangibles | 0 | 14 | 16 | 18 | 20 |
| TOTAL | $13 | $14 | $16 | $19 | $23 |
| Total Assets | $38 | $17 | $26 | $35 | $46 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 107 | 82 | 73 | 630 | 630 |
| Accrued Expenses | 139 | 127 | 119 | 110 | 102 |
| Other current liabilities | 141 | 141 | 141 | 141 | 141 |
| TOTAL | $406 | $349 | $335 | $890 | $889 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 372 | 359 | 346 | 327 | 303 |
| TOTAL | $372 | $359 | $346 | $327 | $303 |
| Total Liabilities | $777 | $708 | $681 | $1,217 | $1,192 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,329 | 82,329 | 82,329 | 82,329 | 82,329 |
| Common Shares | 82 | 82 | 82 | 82 | 82 |
| Retained earnings | -12,605 | -12,557 | -12,521 | -13,047 | -13,012 |
| Other shareholders' equity | 49 | 49 | 49 | 49 | 49 |
| TOTAL | $-740 | $-691 | $-656 | $-1,182 | $-1,147 |
| Total Liabilities And Equity | $38 | $17 | $26 | $35 | $46 |